MDS · Pharmaceutical care · AI

Monitored dosage systems

Three tools for the compliance-aid service in your pharmacy: score whether a patient is a candidate, check which medicines can safely be blistered, and ask an assistant about the service itself.

A professional support tool. Guidance only. It does not replace your professional judgement or the Summary of Product Characteristics. Whether a medicine can be repackaged, and whether a patient should have a compliance aid, depend on the individual case.

This page is written from Spain. The clinical criteria for repackaging are the same anywhere — they come from the dose form and the stability of the product — but the legal and regulatory sections are specific to Spain, and they are labelled as such. Where the UK position differs, it is stated. Follow your own regulator wherever you practise.

What a monitored dosage system is

A monitored dosage system (MDS) — also called a dosette box, a blister pack or a multi-compartment compliance aid — is a sealed tray into which a pharmacist repackages a patient's solid oral medicines, laid out by day and by time of day. It is a professional service that happens after dispensing: the therapy is reviewed, what can safely be repackaged is repackaged, the tray is labelled, and the patient is followed up.

It is not the same as a pill organiser the patient fills themselves. Those are not sealed, carry no traceability and involve no pharmacist check — which is precisely what an MDS adds, and what makes it a service rather than a box.

Manual

The pharmacist places the solid forms into the wells of the tray and seals it with foil or film.

Semi-automated

A loading tray plus software that checks batch numbers, expiry dates and traceability, and flags interactions.

Automated

Robots that fill trays or pouches in bulk, with a Datamatrix code for traceability.

An MDS is not automatically the right answer. The Royal Pharmaceutical Society's position is that a compliance aid should not be the first response to poor adherence: find out why the patient is not taking their medicines first. Often the better answer is a medication review that removes doses, a simpler regimen, larger-print labels, easier-open containers or a reminder chart. An MDS also hides the original packaging and its patient information, makes a tablet harder to identify, and costs pharmacy time every cycle. Use it when it is genuinely the right intervention.

1 Is this patient a candidate? — Suitability score

Answer a few questions about the patient and we will tell you how strong the case is.

The strongest candidates are patients who struggle to follow their treatment: several medicines a day, several doses, frequent missed doses, cognitive impairment, dexterity or eyesight problems, or nobody at home to help. Remember the caveat above: score high, then ask whether a simpler regimen would do the job better.

2 Can it be blistered? — Medicine checker

Add the patient's medicines and we will tell you which are suitable, which need care and which must stay out. Anything we do not hold is passed to the assistant.

Common ones:

    3 Ask the MDS assistant

    Questions about the procedure, storage, how long a filled tray keeps, the records to hold or one particular drug? Ask the assistant — guidance only.

    What can go in, and what cannot

    Only solid oral dose forms are repackaged. Whether a product is suitable depends on how stable it is outside its own container, on how toxic it is, and on the risk of cross-contamination.

    Can go in

    • Film-coated and uncoated tablets
    • Hard and soft capsules, caplets, sugar-coated tablets
    • Whole, or split where the form allows it
    • Light-sensitive or hygroscopic products: in their primary packaging (telling the patient to remove it before taking the dose) or in an amber tray

    Must stay out

    • Oral liquids (syrups, drops, eye baths)
    • Granules and powders
    • Topical products (creams, ointments, emulsions, patches)
    • Inhaled (sprays), nasal, rectal (suppositories), vaginal (pessaries) and sterile products
    • Effervescent, sublingual and orodispersible tablets, and unstable light-sensitive products
    • Modified or prolonged release tablets and capsules (they cannot be split)
    • Heat-sensitive products (fridge storage, 2-8 °C)

    What cannot go in is given separately and must appear on the label of the tray, so nobody assumes the tray is the whole treatment. When stability is in doubt, the Summary of Product Characteristics wins.

    The service, step by step

    1. Indication and suitability. Three things have to hold: that it is indicated, that the medicines can be repackaged, and that the patient or carer can actually use it.
    2. Medication review. Before anything is filled, review the therapy and resolve what you find — interactions, duplicates, doses that could be dropped. Repackaging a bad regimen just makes it tidier.
    3. Consent and custody. The patient agrees to the service and to their medicines being held at the pharmacy to be prepared.
    4. Repackaging. At 15-25 °C and 40-60 % relative humidity, laid out by day and time, with batch, expiry and traceability recorded.
    5. Check they can use it. With a placebo tray, the patient or carer should be able to find and get out the dose for a given moment.
    6. Handover and labelling. Given out with the full label and the patient information leaflets.
    7. Follow-up. Reviewed regularly and updated whenever the prescriber or the patient reports a change.

    Storage and how long it keeps

    What the label has to say

    If it does not fit on the tray, this information has to reach the patient another way — an instruction sheet, the leaflet or a QR code. For blind patients, include braille.

    The legal side — Spain

    This section is Spanish law and does not apply elsewhere. It is here because the rest of the site is written for pharmacies in Spain. In the UK the framework is completely different — the service sits under the GPhC standards and, where an aid is provided as a reasonable adjustment, under the Equality Act. Check what applies where you practise.

    Frequently asked questions

    What is a monitored dosage system (MDS)?

    A monitored dosage system — also called a dosette box, a blister pack or a multi-compartment compliance aid — is a sealed tray in which a pharmacist repackages a patient's solid oral medicines, laid out by day and by time of day. It is a professional service that happens after dispensing: the pharmacist checks the therapy, repackages what can safely be repackaged, labels it and follows it up.

    Which medicines cannot go into a blister pack?

    Anything that is not a stable solid oral dose form: oral liquids, drops, sachets, effervescent, sublingual and orodispersible tablets, inhalers, patches, creams, suppositories, pessaries, eye and ear preparations, and anything injectable or kept in the fridge. Modified and prolonged release forms usually stay out too, because they cannot be split and their stability out of the original pack is often unknown. Warfarin and other drugs titrated to a blood result should not go into a fixed-dose blister at all.

    Who is a candidate for an MDS?

    Patients on several long-term medicines with several doses a day who are forgetting doses, or who have cognitive impairment, dexterity or eyesight problems, a complicated schedule, no support at home, or several different prescribers. The tool on this page scores those factors. But an MDS is not automatically the answer — see the question below.

    Is an MDS always the right answer?

    No, and this is worth saying plainly. The Royal Pharmaceutical Society's position is that a compliance aid should not be the first response to poor adherence: first find out WHY the patient is not taking their medicines. Often the better answer is a medication review that removes doses, a simpler regimen, larger-print labels, easier-open containers, a reminder chart or an alarm. An MDS also hides the original packaging and its patient information, makes it harder to spot what a tablet is, and takes pharmacy time every single cycle. Use it when it is genuinely the right intervention for that patient.

    How long does a filled blister last, and how is it stored?

    As a general rule, no more than 2 weeks from the moment the medicine leaves its original pack to the last dose taken; longer needs stability data for the specific product. The Royal Pharmaceutical Society sets 8 weeks as the outer limit for repackaged medicines without stability data. Keep the filled tray cool and dry, between 8 and 25 °C, out of the light and away from moisture, and never date it beyond the earliest expiry of any medicine in it.

    Can I repackage modified or prolonged release capsules?

    It is not recommended. Modified, prolonged and delayed release forms cannot be split, and once out of their original container their stability is often unknown. Check the Summary of Product Characteristics for the specific product, and if there is no data, leave it out and give it separately — noting on the label that it is part of the treatment but not in the tray.

    Sources

    Every classification here is guidance. When in doubt the Summary of Product Characteristics wins, and so does your own judgement.

    Free Windows program for MDS — Spain

    The tools above help decide whether a patient is a candidate and what can go into a pack. To run the service day to day there is also a free (freeware) desktop program for Windows built for the pharmacy: patients, schedules, boxes in custody, preparation, labels and consent forms in one place. It is written by the author of this site, a pharmacist. It is in Spanish and built for the Spanish rules (AEMPS and CIMA), so it is mainly useful to pharmacies in Spain.

    Patients and schedulePatient and care-home details, and an editable schedule (days, times, cycles, "as needed"). A change never overwrites the old one: a new version is kept, with who and when.
    Boxes by DataMatrixEach box that comes in is logged with national code, batch, expiry and serial number read from the DataMatrix. On an ambiguous code the program stops and asks; it never guesses a batch.
    Prepare and validateFilling order, a scanner check of every box, and validation by a pharmacist under their own user. It records which batch went into which blister, useful after a quality alert.
    Labels and A4 sheetLabels for a roll printer, a label sheet or an adjustable A4 page, save as PDF, and an administration-plan sheet for the patient, also in large print.
    CIMA lookupProduct information, photo and tablet description from the Spanish medicines agency. Only the national code or the drug name is sent to CIMA, never patient data.
    Data on your own computerEverything stays on the pharmacy computer, with a password, a recovery key, an audit log and backups. No cloud, no account.
    Box entry screen of the SPD program: DataMatrix reading, batch, expiry and days of coverage
    Box entry with batch and expiry
    Blister validation screen of the SPD program, with the map of doses by day
    Blister validation by a pharmacist
    Blister label preview in the SPD program, with the print options
    Label and print options

    Before you use it: the program organises, records and prints; it does not decide doses or treatments and does not replace the pharmacist or the official product information, and the pharmacy is responsible for checking every preparation and for its patients' data. The installer is not yet digitally signed, so Windows may show a SmartScreen warning ("More info" → "Run anyway"); a SHA-256 checksum is published with each version. The consent forms it includes are generic drafts: have a legal professional review them before use. It is offered "as is", with no warranty or support. Remember that MDS needs the pharmacy's responsible declaration to the regional authority (see above).